OLIGOMETASTATIC PROSTATE CARCINOMA
Clinical trials for OLIGOMETASTATIC PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OLIGOMETASTATIC PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for OLIGOMETASTATIC PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Tumor-Seeking' radiation therapy enters human trials for prostate cancer
Disease control OngoingThis clinical trial is testing a new targeted radiation treatment called [Ac-225]-PSMA-62 for men with advanced prostate cancer that has spread. The treatment uses a radioactive drug designed to find and deliver radiation directly to prostate cancer cells throughout the body. The…
Matched conditions: OLIGOMETASTATIC PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
Shorter radiation course tested for prostate cancer that has returned
Disease control OngoingThis study is testing if a shorter, more intense course of radiation is safe and effective for men whose prostate cancer has returned or spread to a few lymph nodes. It compares two radiation methods—proton therapy and standard IMRT—to see which one causes fewer serious side effe…
Matched conditions: OLIGOMETASTATIC PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC